187 related articles for article (PubMed ID: 11726664)
21. CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer.
Zeigler-Johnson C; Friebel T; Walker AH; Wang Y; Spangler E; Panossian S; Patacsil M; Aplenc R; Wein AJ; Malkowicz SB; Rebbeck TR
Cancer Res; 2004 Nov; 64(22):8461-7. PubMed ID: 15548719
[TBL] [Abstract][Full Text] [Related]
22. Expression of cytochromes P450 3A and P-glycoprotein in human large intestine in paired tumour and normal samples.
Canaparo R; Nordmark A; Finnström N; Lundgren S; Seidegård J; Jeppsson B; Edwards RJ; Boobis AR; Rane A
Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):240-8. PubMed ID: 17371528
[TBL] [Abstract][Full Text] [Related]
23. Cloning, sequencing, heterologous expression, and characterization of murine cytochrome P450 3a25*(Cyp3a25), a testosterone 6beta-hydroxylase.
Dai D; Bai R; Hodgson E; Rose RL
J Biochem Mol Toxicol; 2001; 15(2):90-9. PubMed ID: 11284050
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of induction of CYP3A mRNA using the HepG2 cell line and reverse transcription-PCR.
Sumida A; Yamamoto I; Zhou Q; Morisaki T; Azuma J
Biol Pharm Bull; 1999 Jan; 22(1):61-5. PubMed ID: 9989663
[TBL] [Abstract][Full Text] [Related]
25. Role of temperature on protein and mRNA cytochrome P450 3A (CYP3A) isozymes expression and midazolam oxidation by cultured rat precision-cut liver slices.
Rekka E; Evdokimova E; Eeckhoudt S; Labar G; Calderon PB
Biochem Pharmacol; 2002 Aug; 64(4):633-43. PubMed ID: 12167482
[TBL] [Abstract][Full Text] [Related]
26. A candidate chimeric mammalian mRNA transcript is derived from distinct chromosomes and is associated with nonconsensus splice junction motifs.
Zhang C; Xie Y; Martignetti JA; Yeo TT; Massa SM; Longo FM
DNA Cell Biol; 2003 May; 22(5):303-15. PubMed ID: 12941158
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of induction of rat hepatic CYP2B and 3A by the pesticide methoxychlor.
Li HC; Kupfer D
J Biochem Mol Toxicol; 1998; 12(6):315-23. PubMed ID: 9736480
[TBL] [Abstract][Full Text] [Related]
28. Identification, characterization, and ontogeny of a second cytochrome P450 3A gene from the fresh water teleost medaka (Oryzias latipes).
Kullman SW; Hinton DE
Mol Reprod Dev; 2001 Feb; 58(2):149-58. PubMed ID: 11139226
[TBL] [Abstract][Full Text] [Related]
29. Significance of the minor cytochrome P450 3A isoforms.
Daly AK
Clin Pharmacokinet; 2006; 45(1):13-31. PubMed ID: 16430309
[TBL] [Abstract][Full Text] [Related]
30. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways.
Cerveny L; Svecova L; Anzenbacherova E; Vrzal R; Staud F; Dvorak Z; Ulrichova J; Anzenbacher P; Pavek P
Drug Metab Dispos; 2007 Jul; 35(7):1032-41. PubMed ID: 17392393
[TBL] [Abstract][Full Text] [Related]
31. Circular RNAs from transcripts of the rat cytochrome P450 2C24 gene: correlation with exon skipping.
Zaphiropoulos PG
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6536-41. PubMed ID: 8692851
[TBL] [Abstract][Full Text] [Related]
32. CYP3A5 mRNA degradation by nonsense-mediated mRNA decay.
Busi F; Cresteil T
Mol Pharmacol; 2005 Sep; 68(3):808-15. PubMed ID: 15955870
[TBL] [Abstract][Full Text] [Related]
33. Genotype relationships in the CYP3A locus in Caucasians.
Dally H; Bartsch H; Jäger B; Edler L; Schmezer P; Spiegelhalder B; Dienemann H; Drings P; Kayser K; Schulz V; Risch A
Cancer Lett; 2004 Apr; 207(1):95-9. PubMed ID: 15050738
[TBL] [Abstract][Full Text] [Related]
34. Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes.
Aitken AE; Morgan ET
Drug Metab Dispos; 2007 Sep; 35(9):1687-93. PubMed ID: 17576808
[TBL] [Abstract][Full Text] [Related]
35. Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man.
Gibson GG; Plant NJ; Swales KE; Ayrton A; El-Sankary W
Xenobiotica; 2002 Mar; 32(3):165-206. PubMed ID: 11958559
[TBL] [Abstract][Full Text] [Related]
36. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver.
Lang T; Klein K; Fischer J; Nüssler AK; Neuhaus P; Hofmann U; Eichelbaum M; Schwab M; Zanger UM
Pharmacogenetics; 2001 Jul; 11(5):399-415. PubMed ID: 11470993
[TBL] [Abstract][Full Text] [Related]
37. Model system for evaluation of alternative splicing: exon skipping.
Yuan ZA; Chen E; Gibson CW
DNA Cell Biol; 2001 Dec; 20(12):807-13. PubMed ID: 11879574
[TBL] [Abstract][Full Text] [Related]
38. Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver.
Mahnke A; Strotkamp D; Roos PH; Hanstein WG; Chabot GG; Nef P
Arch Biochem Biophys; 1997 Jan; 337(1):62-8. PubMed ID: 8990268
[TBL] [Abstract][Full Text] [Related]
39. Modulation of MDR1 and CYP3A expression by dexamethasone: evidence for an inverse regulation in adrenals.
Sérée E; Villard PH; Hevér A; Guigal N; Puyoou F; Charvet B; Point-Scomma H; Lechevalier E; Lacarelle B; Barra Y
Biochem Biophys Res Commun; 1998 Nov; 252(2):392-5. PubMed ID: 9826540
[TBL] [Abstract][Full Text] [Related]
40. Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokinetics.
Gashaw I; Kirchheiner J; Goldammer M; Bauer S; Seidemann J; Zoller K; Mrozikiewicz PM; Roots I; Brockmöller J
Clin Pharmacol Ther; 2003 Nov; 74(5):448-57. PubMed ID: 14586385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]